Nevro (NYSE: NVRO) is a public multinational medical technology company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has impacted the lives of over 36,000 patients around the world.
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
The primary focus of the role is to manage and lead sales strategy and execution for Nevro. The US Sales organization is growing aggressively and already has over two hundred and thirty sales professionals split into three national areas and multiple regions. This will include translating the overall strategy into tactical growth plans with metric driven processes to ensure outcomes and financial goals are achieved.
The role will also encompass international commercial responsibility focused on key strategic markets. While these markets are important, the main emphasis for the individual will be to drive the US market revenues.
The role will require an individual to establish a results- and performance-based culture while infusing a robust level of processes and prioritization. This person should also have a demonstrated track record of recruiting and fielding an "A+" team of sales professionals. In addition to hiring, training, motivating and leading the sales organization, the VP of Sales will be a professional "relationship developer", an executive with a proven track record in developing and driving high quality customer relationships.
The role will also require a business-oriented executive who recognizes changing market dynamics and will contribute to Nevro’s overall strategy in a collaborative way.